Hospital characteristics and perioperative complications of Hispanic patients following reverse shoulder arthroplasty—a large database study

• Published in: Arthroplasty 2023-10, Vol.5 (1), p.50-50, Article 50
• Main Authors: Venishetty, Nikit, Sohn, Garrett, Nguyen, Ivy, Trivedi, Meesha, Mounasamy, Varatharaj, Sambandam, Senthil
• Format: Article
• Language: English
• Subjects: Cost of care; Disparities in healthcare; Hispanic patients; Length of stay; Perioperative complications; Reverse shoulder arthroplasty
• ISSN: 2524-7948; 2524-7948
• DOI: 10.1186/s42836-023-00206-2

BACKGROUNDHispanic patients are the youngest and fastest-growing ethnic group in the USA. Many of these patients are increasingly met with orthopedic issues, often electing to undergo corrective procedures such as reverse shoulder arthroplasty (RSA). This patient population has unique medical needs and has been reported to have higher incidences of perioperative complications following major procedures. Unfortunately, there is a lack of information on the hospitalization data and perioperative complications in Hispanic patients following procedures such as RSA. This project aimed to query the Nationwide Inpatient Sample (NIS) database to assess patient hospitalization information, demographics, and the prevalence of perioperative complications among Hispanic patients who received RSA.METHODSInformation from 2016-2019 was queried from the NIS database. Demographic information, incidences of perioperative complications, length of stay, and costs of care among Hispanic patients undergoing RSA were compared to non-Hispanic patients undergoing RSA. A subsequent propensity matching was conducted to consider preoperative comorbidities.RESULTSThe query of NIS identified 59,916 patients who underwent RSA. Of this sample, 2,656 patients (4.4%) were identified to be Hispanic, while the remaining 57,260 patients (95.6%) were found to belong to other races (control). After propensity matching, Hispanic patients had a significantly longer LOS (median = 1.4 days) than the patients in the control group (median = 1.0, P